Clinton Wilkinson, MD
Critical Care Medicine · Charlottesville, VANPI 1326609058
Payments from drug & device makers
What this record shows
The money is spread across several categories — food and beverage (47.5%), travel and lodging and education — rather than concentrated in one kind of arrangement. 12 manufacturers reported payments, led by Medtronic at 30.6% of the total. Reporting peaked in 2024 at $4,219 and has fallen 59.4% since, to $1,714 in 2025.
Across 119 payments — averaging $74.94 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Medtronic$3K
- Boston Scientific$2K
- Spinal Simplicity, LLC$2K
- Nevro Corp.$937
- Abbott$563
- MML US, Inc.$146
- plus $308 from 6 others
What the payments were for
- Travel & lodging$3,88044%
- Food & beverage$4,23447%
- Education$8039%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Medtronic | 26 | $2,728 |
| Boston Scientific | 29 | $2,164 |
| Spinal Simplicity, LLC | 24 | $2,072 |
| Nevro Corp. | 6 | $937 |
| Abbott | 15 | $563 |
| MML US, Inc. | 2 | $146 |
| Curonix LLC | 6 | $95 |
| Globus Medical | 3 | $69 |
| SPR Therapeutics, Inc | 2 | $61 |
| Foundation Fusion Solutions, LLC | 4 | $46 |
| AbbVie | 1 | $24 |
| Stryker | 1 | $14 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- HA MINUTEMAN G3-R$1,781
- KYPHON EXPRESS II KYPHOPAK TRAY$968
- VANTA ADAPTIVESTIM$935
- Omnia$767
- WaveWriter Alpha Prime 16$548
- PROCLAIM$180
- Intracept$147
- GENERAL PAIN MANAGEMENT$131
- ReActiv8$124
- SYNCHROMEDII$120
How this compares
$8,917 in reported general payments places this provider in the 85th percentile of 174 critical care medicine providers in Virginia.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Buprenorphine | 47 | $10,589 |
| BelbucaBuprenorphine Hcl | 15 | $8,751 |
| Oxycodone-AcetaminophenOxycodone Hcl/Acetaminophen | 139 | $3,260 |
| Hydrocodone-AcetaminophenHydrocodone/Acetaminophen | 181 | $2,893 |
| Pregabalin | 126 | $2,844 |
| Gabapentin | 148 | $1,799 |
| Diclofenac Sodium | 22 | $1,562 |
| Tramadol Hcl ErTramadol Hcl | 21 | $1,128 |
| Tizanidine Hcl | 87 | $1,101 |
| Baclofen | 82 | $989 |
| Lidocaine | 11 | $854 |
| Duloxetine Hcl | 60 | $792 |
| Tramadol Hcl | 81 | $543 |
| Methocarbamol | 47 | $413 |
| Morphine Sulfate ErMorphine Sulfate | 15 | $296 |
Paid to pharmacies, not to this prescriber.
Other critical care medicine in Charlottesville
- Robert ThieleCharlottesville$52K
- Taison BellCharlottesville$7K
- Michael MazzeffiCharlottesville$7K
- Akram ZaaqoqCharlottesville$6K
- Yun ShimCharlottesville$4K
- Matthew HulseCharlottesville$3K
- Danny TheodoreCharlottesville$3K
- Joshua MakepeaceCharlottesville$1K
- David StombaughCharlottesville$823
- Samuel OliverCharlottesville$789
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.